High Variability in Outcomes of Two-Stage Exchange to Treat Periprosthetic Joint Infection

Authors

Benjamin Zmistowski, BS, Rothman Institute of Orthopaedics at the Thomas Jefferson UniversityFollow
Paul Lichstein, MD, Rothman Institute of Orthopaedics at the Thomas Jefferson UniversityFollow
Aaron H Carter, MD, Rothman Institute, Thomas Jefferson UniversityFollow
Joshua J. Minori, DO, Rothman Institute of Orthopaedics at the Thomas Jefferson UniversityFollow
Javad Parvizi, MD, Rothman Institute, Thomas Jefferson UniversityFollow

Document Type

Poster

Publication Date

3-2014

Comments

Conference poster presented at: 2014 meeting of the American Academy of Orthopaedic Surgeons in New Orleans, Louisiana

Abstract

Introduction:

Periprosthetic joint infection (PJI) is a challenging condition to manage with sobering morbidity and mortality.1,2 Treatment options range from simple irrigation and debridement with prosthetic retention to explantation and placement of a temporary cement spacer. Indictations for each option are unclear and non-uniform despite signi­cant efforts to understand the management outcomes. Until recently, a uniform de­nition of success was unavailable, thus clouding the discussion of treatment options. Two-stage exchange is currently considered the “gold-standard” in North America, yet an appropriate understanding of the actual success and ancillary effects of treatment is needed. With the advantage of an expert opinion de­ning success, this study was designed to understand the status of the current literature and the guidance it provides regarding two-stage exchange arthroplasty.

Recommended Citation

Zmistowski, BS, Benjamin; Lichstein, MD, Paul; Carter, MD, Aaron H; Minori, DO, Joshua J.; and Parvizi, MD, Javad, "High Variability in Outcomes of Two-Stage Exchange to Treat Periprosthetic Joint Infection" (2014). Rothman Institute Conference Posters. Paper 3.
https://jdc.jefferson.edu/rothinsposters/3